Concepedia

Publication | Closed Access

The Antioxidant Acetylcysteine Reduces Cardiovascular Events in Patients With End-Stage Renal Failure

DOI

370

Citations

20

References

2003

Year

Martin Tepel, Markus van der Giet, Mario Statz, Joachim Jankowski, Walter Zidek
Circulation

Abstract

In hemodialysis patients, treatment with acetylcysteine (600 mg BID) reduces composite cardiovascular end points.

References

YearCitations

Page 1